| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.35 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |